![Marvin Moser](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marvin Moser
Directeur/Bestuurslid bij The Trudeau Institute
Profiel
Marvin Moser is a Trustee at The Trudeau Institute.
Previously, he was a Director at NXXI, Inc. from 1997 to 2008.
He was also a Trustee at Comprehensive NeuroScience, Inc. Dr. Moser received his undergraduate degree from Cornell University.
Actieve functies van Marvin Moser
Bedrijven | Functie | Begin |
---|---|---|
The Trudeau Institute | Directeur/Bestuurslid | - |
Eerdere bekende functies van Marvin Moser
Bedrijven | Functie | Einde |
---|---|---|
NXXI, Inc.
![]() NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | Directeur/Bestuurslid | 13-07-2008 |
Comprehensive NeuroScience, Inc.
![]() Comprehensive NeuroScience, Inc. Miscellaneous Commercial ServicesCommercial Services Comprehensive NeuroScience (CNS) is a strategic clinical research partner providing a full range of services in various therapeutic areas with an outstanding record for consistently delivering quality and success on time and within budget. CNS continues to dominate the therapeutic development process by standing as a strategic partner poised with expertise in central nervous system disorders and multiple therapeutic areas, research methodologies, regulatory requisites and evolving patient needs. CNS is dedicated to open and effective communication at all organizational levels, and to supporting sponsor confidence through simplified contracting, timely enrollment, proactive trial execution, and quality data delivery. CNS delivers accelerated product development that is coupled with integrated clinical trial management services and high quality investigative site research services for all phases within three separate divisions. | Directeur/Bestuurslid | - |
Opleiding van Marvin Moser
Cornell University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
NXXI, Inc.
![]() NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | Health Technology |
Comprehensive NeuroScience, Inc.
![]() Comprehensive NeuroScience, Inc. Miscellaneous Commercial ServicesCommercial Services Comprehensive NeuroScience (CNS) is a strategic clinical research partner providing a full range of services in various therapeutic areas with an outstanding record for consistently delivering quality and success on time and within budget. CNS continues to dominate the therapeutic development process by standing as a strategic partner poised with expertise in central nervous system disorders and multiple therapeutic areas, research methodologies, regulatory requisites and evolving patient needs. CNS is dedicated to open and effective communication at all organizational levels, and to supporting sponsor confidence through simplified contracting, timely enrollment, proactive trial execution, and quality data delivery. CNS delivers accelerated product development that is coupled with integrated clinical trial management services and high quality investigative site research services for all phases within three separate divisions. | Commercial Services |
The Trudeau Institute |